| Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers (NCT01490008) | MediGene | 2011-12-01 |
| Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation (NCT01516983) | Betta Pharmaceuticals Co., Ltd. | 2011-12-01 |
| Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy (NCT01497964) | Sanofi | 2011-12-01 |
| Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol (NCT01498861) | ViiV Healthcare | 2011-12-01 |
| A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects (NCT01503866) | Biogen | 2011-12-01 |
| Dose Escalation Study of Pazopanib Plus TH-302 (NCT01485042) | Herbert Hurwitz, MD | 2011-12-01 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects (NCT01487239) | Genentech, Inc. | 2011-12-01 |
| The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas (NCT01567475) | The Lymphoma Academic Research Organisation | 2011-12-01 |
| Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease (NCT01502735) | U.S. Army Medical Research and Development Command | 2011-12-01 |
| Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS (NCT01450280) | University of Oxford | 2011-12-01 |
| Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia (NCT01501617) | Histogen | 2011-12-01 |
| Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX® (NCT01500122) | MediGene | 2011-12-01 |
| Image Guided Reirradiation of High-grade Glioma (NCT02025231) | Rigshospitalet, Denmark | 2011-12-01 |
| Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia (NCT01456182) | Afexa Life Sciences Inc | 2011-12-01 |
| Comparison of a Drug and Placebo in the Prevention of Migraine Headaches (NCT01122381) | US Department of Veterans Affairs | 2011-12-01 |
| Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens (NCT01502085) | Hackensack Meridian Health | 2011-12-01 |
| Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma (NCT01428492) | Novartis | 2011-12-01 |
| Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone (NCT01498718) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression (NCT02378415) | United States Naval Medical Center, San Diego | 2011-12-01 |
| Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia (NCT01506544) | Children's Mercy Hospital Kansas City | 2011-12-01 |
| Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects (NCT01487135) | FORUM Pharmaceuticals Inc | 2011-12-01 |
| A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers (NCT01489306) | MicroDose Therapeutx, Inc | 2011-12-01 |
| Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer (NCT01502592) | Memorial Sloan Kettering Cancer Center | 2011-12-01 |
| A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL) (NCT01456039) | Celgene | 2011-12-01 |
| Use of Adult Bone Marrow Mononuclear Cells in Patients With Long Bone Nonunion (NCT01581892) | Hospital Universitario Central de Asturias | 2011-12-01 |
| A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia (NCT01493726) | Alkermes, Inc. | 2011-12-01 |
| TP0501 - Pharmaco-Scintigraphic-Study (NCT02306772) | Tillotts Pharma AG | 2011-12-01 |
| Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia (NCT01439971) | Catalyst Biosciences | 2011-12-01 |
| An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) (NCT01494701) | Biogen | 2011-11-30 |
| Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite (NCT01480609) | GlaxoSmithKline | 2011-11-30 |
| Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma (NCT01484093) | Memorial Sloan Kettering Cancer Center | 2011-11-29 |
| RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA (NCT01497808) | Abramson Cancer Center at Penn Medicine | 2011-11-29 |
| Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults (NCT01419535) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2011-11-29 |
| A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors (NCT01478685) | Celgene | 2011-11-29 |
| A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects (NCT01461460) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-11-28 |
| Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis (NCT01541670) | Baxalta now part of Shire | 2011-11-28 |
| A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278 (NCT01573819) | GlaxoSmithKline | 2011-11-24 |
| Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer (NCT01480154) | National Cancer Institute (NCI) | 2011-11-23 |
| BG & TMZ Therapy of Glioblastoma Multiforme (NCT01269424) | Stanton Gerson MD | 2011-11-22 |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously (NCT01543672) | The Netherlands Cancer Institute | 2011-11-22 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers (NCT01640990) | GlaxoSmithKline | 2011-11-22 |
| Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease (NCT01602900) | GlaxoSmithKline | 2011-11-22 |
| Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT01349049) | Daiichi Sankyo | 2011-11-21 |
| Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649) (NCT01451437) | Merck Sharp & Dohme LLC | 2011-11-18 |
| Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer (NCT01460537) | Bayer | 2011-11-18 |
| A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults. (NCT01490788) | Tonix Pharmaceuticals, Inc. | 2011-11-18 |
| BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer (NCT01339442) | Washington University School of Medicine | 2011-11-14 |
| Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications (NCT01633229) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-11-14 |
| Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors (NCT01434316) | National Cancer Institute (NCI) | 2011-11-11 |
| Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD) (NCT01499888) | University of Illinois at Chicago | 2011-11-11 |
| A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency (NCT01458067) | GlaxoSmithKline | 2011-11-10 |
| Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement (NCT00869024) | University of Minnesota | 2011-11-10 |
| Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma (NCT01454076) | Millennium Pharmaceuticals, Inc. | 2011-11-10 |
| A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513) (NCT01465412) | Merck Sharp & Dohme LLC | 2011-11-10 |
| Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide (NCT01458366) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-11-09 |
| Combined Deep Brain Stimulation for Parkinson's Disease (NCT01485276) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-11-08 |
| Pericardiocentesis With Magnetic Resonance Imaging (NCT01479569) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-11-08 |
| A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers (NCT01620931) | Hoffmann-La Roche | 2011-11-07 |
| A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers (NCT01545570) | GlaxoSmithKline | 2011-11-07 |
| Clinical Trial of Comparative Study of GB221 Pharmacokinetics (NCT04175171) | Genor Biopharma Co., Ltd. | 2011-11-07 |
| Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine (NCT01469637) | Shire | 2011-11-07 |
| A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia (NCT01495026) | GlaxoSmithKline | 2011-11-06 |
| A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001) (NCT01358331) | Merck Sharp & Dohme LLC | 2011-11-04 |
| 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors (NCT01470365) | Fox Chase Cancer Center | 2011-11-03 |
| A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ (NCT01597648) | GlaxoSmithKline | 2011-11-01 |
| A Study of LY2140023 in Hepatically-Impaired Participants (NCT01475136) | Denovo Biopharma LLC | 2011-11-01 |
| Promotion of Self-help Strategies for Depression (NCT01399502) | Orygen | 2011-11-01 |
| A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer (NCT01469793) | Genentech, Inc. | 2011-11-01 |
| Comparison Between Deep Sclerectomy and Traditional Trabeculotomy & Trabeculectomy in Congenital Glaucoma (NCT01460017) | King Saud University | 2011-11-01 |
| Renal Denervation in Patients With Uncontrolled Hypertension in Chinese (NCT01390831) | The Second People's Hospital of Chengdu | 2011-11-01 |
| Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma (NCT01503177) | Mayo Clinic | 2011-11-01 |
| A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors (NCT01455532) | Sanofi | 2011-11-01 |
| Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects (NCT01470911) | Sterna Biologicals GmbH & Co. KG | 2011-11-01 |
| Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis (NCT01967134) | Aeras | 2011-11-01 |
| A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155) (NCT01451619) | Merck Sharp & Dohme LLC | 2011-11-01 |
| Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects (NCT01399255) | Wockhardt | 2011-11-01 |
| Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects (NCT01473173) | HK inno.N Corporation | 2011-11-01 |
| Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers (NCT01478893) | Selecta Biosciences, Inc. | 2011-11-01 |
| Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer (NCT01493310) | University of Chicago | 2011-11-01 |
| Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma (NCT01455103) | Bristol-Myers Squibb | 2011-11-01 |
| A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma (NCT01432951) | Eli Lilly and Company | 2011-11-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients (NCT01487460) | Novartis Pharmaceuticals | 2011-11-01 |
| GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects (NCT01459315) | University of North Carolina, Chapel Hill | 2011-11-01 |
| Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients (NCT01641536) | Genexine, Inc. | 2011-11-01 |
| An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors (NCT01466569) | AbGenomics B.V Taiwan Branch | 2011-11-01 |
| Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) (NCT01400451) | Bristol-Myers Squibb | 2011-11-01 |
| Hyperinsulinemic Euglycemic Clamp Protocol (NCT01408667) | Torrent Pharmaceuticals Limited | 2011-11-01 |
| Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655) (NCT01432535) | Merck Sharp & Dohme LLC | 2011-11-01 |
| E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer (NCT01355302) | Eisai Inc. | 2011-11-01 |
| Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma (NCT01586182) | Dana-Farber Cancer Institute | 2011-11-01 |
| Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation (NCT01472783) | Vejle Hospital | 2011-11-01 |
| Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan (NCT01609907) | Yuhan Corporation | 2011-11-01 |
| Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation (NCT01483183) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-11-01 |
| Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects (NCT01477619) | Vanda Pharmaceuticals | 2011-11-01 |
| Single Ascending Dose Trial in Patients With Type 2 Diabetes (NCT01492465) | Amgen | 2011-11-01 |
| A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers (NCT02199392) | Eisai Inc. | 2011-11-01 |
| Single Center Food Allergy Oral Immunotherapy Study (NCT01490177) | Stanford University | 2011-11-01 |
| Heat Retention Head Wrap Use for Re-warming of Infants Requiring Cardio-Pulmonary Bypass (NCT01675830) | Cardiology Clinical Research & Regulatory Group | 2011-11-01 |
| Dexpramipexole SAD/MAD Study (NCT01449578) | Knopp Biosciences | 2011-11-01 |
| A Healthy Female and Male Volunteers Aspirin Study (NCT01448031) | AstraZeneca | 2011-11-01 |